AOX1
Aldehyde oxidase
Also known as: AO, AOH1, AOXA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q06278
- Gene
- AOX1
- Ensembl
- ENSG00000138356
- Chromosome
- 2
- Canonical length
- 1338 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nuclear bodies,Microtubules,Cytokinetic bridge,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Aldehyde oxidase produces hydrogen peroxide and, under certain conditions, can catalyze the formation of superoxide. Aldehyde oxidase is a candidate gene for amyotrophic lateral sclerosis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1338 residues, UniProt reviewed canonical sequence.
>Q06278|AOX1
1 MDRASELLFY VNGRKVIEKN VDPETMLLPY LRKKLRLTGT KYGCGGGGCG ACTVMISRYN
61 PITKRIRHHP ANACLIPICS LYGAAVTTVE GIGSTHTRIH PVQERIAKCH GTQCGFCTPG
121 MVMSIYTLLR NHPEPTLDQL TDALGGNLCR CTGYRPIIDA CKTFCKTSGC CQSKENGVCC
181 LDQGINGLPE FEEGSKTSPK LFAEEEFLPL DPTQELIFPP ELMIMAEKQS QRTRVFGSER
241 MMWFSPVTLK ELLEFKFKYP QAPVIMGNTS VGPEVKFKGV FHPVIISPDR IEELSVVNHA
301 YNGLTLGAGL SLAQVKDILA DVVQKLPEEK TQMYHALLKH LGTLAGSQIR NMASLGGHII
361 SRHPDSDLNP ILAVGNCTLN LLSKEGKRQI PLNEQFLSKC PNADLKPQEI LVSVNIPYSR
421 KWEFVSAFRQ AQRQENALAI VNSGMRVFFG EGDGIIRELC ISYGGVGPAT ICAKNSCQKL
481 IGRHWNEQML DIACRLILNE VSLLGSAPGG KVEFKRTLII SFLFKFYLEV SQILKKMDPV
541 HYPSLADKYE SALEDLHSKH HCSTLKYQNI GPKQHPEDPI GHPIMHLSGV KHATGEAIYC
601 DDMPLVDQEL FLTFVTSSRA HAKIVSIDLS EALSMPGVVD IMTAEHLSDV NSFCFFTEAE
661 KFLATDKVFC VGQLVCAVLA DSEVQAKRAA KRVKIVYQDL EPLILTIEES IQHNSSFKPE
721 RKLEYGNVDE AFKVVDQILE GEIHMGGQEH FYMETQSMLV VPKGEDQEMD VYVSTQFPKY
781 IQDIVASTLK LPANKVMCHV RRVGGAFGGK VLKTGIIAAV TAFAANKHGR AVRCVLERGE
841 DMLITGGRHP YLGKYKAGFM NDGRILALDM EHYSNAGASL DESLFVIEMG LLKMDNAYKF
901 PNLRCRGWAC RTNLPSNTAF RGFGFPQAAL ITESCITEVA AKCGLSPEKV RIINMYKEID
961 QTPYKQEINA KNLIQCWREC MAMSSYSLRK VAVEKFNAEN YWKKKGLAMV PLKFPVGLGS
1021 RAAGQAAALV HIYLDGSVLV THGGIEMGQG VHTKMIQVVS RELRMPMSNV HLRGTSTETV
1081 PNANISGGSV VADLNGLAVK DACQTLLKRL EPIISKNPKG TWKDWAQTAF DESINLSAVG
1141 YFRGYESDMN WEKGEGQPFE YFVYGAACSE VEIDCLTGDH KNIRTDIVMD VGCSINPAID
1201 IGQIEGAFIQ GMGLYTIEEL NYSPQGILHT RGPDQYKIPA ICDMPTELHI ALLPPSQNSN
1261 TLYSSKGLGE SGVFLGCSVF FAIHDAVSAA RQERGLHGPL TLNSPLTPEK IRMACEDKFT
1321 KMIPRDEPGS YVPWNVPILocalizationUniProt · AlphaFold · HPA
Whether an antibody against AOX1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.2
- Highest tissue expression
- 833 nTPM
Expression across tissuesHPA
Tissue
- liver: 833 nTPM
- adrenal gland: 284 nTPM
- kidney: 96 nTPM
- adipose tissue: 87 nTPM
- pancreas: 84 nTPM
- breast: 52 nTPM
Single-cell type
- hepatocytes: 1,128 nCPM
- adrenal cortex cells: 896 nCPM
- mesothelial cells: 434 nCPM
- leydig cells: 189 nCPM
- pancreatic acinar cells: 178 nCPM
- peritubular myoid cells: 176 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 10 nTPM
- choroid plexus: 9.8 nTPM
- white matter: 9.5 nTPM
- cerebral cortex: 8.6 nTPM
- basal ganglia: 8 nTPM
- hypothalamus: 5.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.18
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- 2 iron, 2 sulfur cluster binding
- aldehyde oxidase activity
- FAD binding
- flavin adenine dinucleotide binding
- identical protein binding
- iron ion binding
- molybdopterin cofactor binding
- NAD binding
- protein homodimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aldehyde oxidase/xanthine dehydrogenase, a/b hammerhead
- 2Fe-2S ferredoxin-type iron-sulfur binding domain
- Molybdopterin dehydrogenase, FAD-binding
- [2Fe-2S]-binding
- CO dehydrogenase flavoprotein, C-terminal
- 2Fe-2S ferredoxin, iron-sulphur binding site
- Aldehyde oxidase/xanthine dehydrogenase, first molybdopterin binding domain
- Beta-grasp domain superfamily
- FAD-binding domain, PCMH-type
- FAD-binding, type PCMH, subdomain 1
- FAD-binding, type PCMH, subdomain 2
- Aldehyde oxidase/xanthine dehydrogenase-like
- Oxidoreductase, molybdopterin binding site
- 2Fe-2S ferredoxin-like superfamily
- FAD-binding, type PCMH-like superfamily
- CO dehydrogenase flavoprotein, C-terminal domain superfamily
- Aldehyde oxidase/xanthine dehydrogenase, a/b hammerhead superfamily
- [2Fe-2S]-binding domain superfamily
- Aldehyde oxidase/xanthine dehydrogenase, molybdopterin binding domain superfamily
- Aldehyde oxidase/xanthine dehydrogenase, second molybdopterin binding domain
- 2Fe-2S iron-sulfur cluster binding domain
- FAD binding domain in molybdopterin dehydrogenase
- Aldehyde oxidase and xanthine dehydrogenase, a/b hammerhead domain
- [2Fe-2S] binding domain
- Molybdopterin cofactor-binding domain
- CO dehydrogenase flavoprotein C-terminal domain
- Molybdopterin cofactor-binding domain
- Aldehyde oxidase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AOX1 as an antibody target. Whether an autoantibody or antibody against AOX1 could matter depends on whether native AOX1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AOX1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AOX1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...